Page last updated: 2024-08-26

monocrotaline pyrrole and Body Weight

monocrotaline pyrrole has been researched along with Body Weight in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19906 (54.55)18.7374
1990's5 (45.45)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruner, LH; Hilliker, KS; Roth, RA1
Hilliker, KS; Roth, RA1
Bell, TG; Hilliker, KS; Lorimer, D; Roth, RA1
Jones, AD; Lamé, MW; Pan, LC; Segall, HJ; Wilson, DW1
Bittner, HB; Chen, EP; Davis, RD; Van Trigt, P1
Roth, RA; Schultze, AE; Wagner, JG1
Roth, RA; Schultze, AE; Wagner, JG; White, SM1
Ganey, PE; Reindel, JF; Roth, RA; Slocombe, RF; Wagner, JG1
Roth, RA; Wagner, JG; White, SM1
Fink, GD; Ganey, PE; Roth, RA1
Bruner, LH; Bull, RW; Roth, RA1

Other Studies

11 other study(ies) available for monocrotaline pyrrole and Body Weight

ArticleYear
Pulmonary hypertension and ECG changes from monocrotaline pyrrole in the rat.
    The American journal of physiology, 1983, Volume: 245, Issue:2

    Topics: Animals; Blood Cell Count; Body Weight; Cardiomegaly; Electrocardiography; Heart; Heart Ventricles; Hypertension, Pulmonary; Kinetics; Lung; Male; Monocrotaline; Organ Size; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains

1983
Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
    British journal of pharmacology, 1984, Volume: 82, Issue:2

    Topics: Animals; Body Weight; Cardiomegaly; Dexamethasone; Heart Diseases; Hydralazine; L-Lactate Dehydrogenase; Lung; Lung Diseases; Monocrotaline; Myocardium; Organ Size; Pyrrolizidine Alkaloids; Rats; Sulfinpyrazone

1984
Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension.
    The American journal of physiology, 1984, Volume: 246, Issue:6 Pt 2

    Topics: Animals; Blood Platelets; Body Weight; Hypertension, Pulmonary; Immune Sera; Lung; Male; Monocrotaline; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Thrombocytosis

1984
COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
    Toxicology and applied pharmacology, 1993, Volume: 118, Issue:1

    Topics: Animals; Body Weight; Cysteine; Glutathione; Lung; Male; Monocrotaline; Pulmonary Heart Disease; Rats; Rats, Sprague-Dawley

1993
Hemodynamic and inotropic effects of nitric oxide in pulmonary hypertension.
    The Journal of surgical research, 1997, Volume: 69, Issue:2

    Topics: Animals; Body Weight; Disease Models, Animal; Dogs; Hemodynamics; Hypertension, Pulmonary; Monocrotaline; Myocardial Contraction; Nitric Oxide; Pulmonary Circulation; Regional Blood Flow; Vascular Resistance

1997
An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrrole.
    Toxicology and applied pharmacology, 1991, Volume: 109, Issue:3

    Topics: Animals; Blood Coagulation; Body Weight; Bronchoalveolar Lavage Fluid; Cardiomegaly; Injections, Intravenous; Lung; Male; Monocrotaline; Organ Size; Partial Thromboplastin Time; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains

1991
Early indications of monocrotaline pyrrole-induced lung injury in rats.
    Toxicology and applied pharmacology, 1991, Jun-01, Volume: 109, Issue:1

    Topics: Animals; Body Weight; Bronchoalveolar Lavage Fluid; L-Lactate Dehydrogenase; Lung; Male; Monocrotaline; Organ Size; Proteins; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Time Factors

1991
Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
    Toxicology and applied pharmacology, 1990, Volume: 106, Issue:2

    Topics: Animals; Biomarkers; Body Weight; Bronchoalveolar Lavage Fluid; Dimethylformamide; Hemodynamics; Hypertension, Pulmonary; Injections, Intravenous; L-Lactate Dehydrogenase; Lung; Male; Monocrotaline; Organ Size; Proteins; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Time Factors

1990
Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats.
    Toxicology and applied pharmacology, 1989, Jun-15, Volume: 99, Issue:2

    Topics: Animals; Blood Platelets; Body Weight; Dimethylformamide; Hemoglobins; Hypertension, Pulmonary; Indium Radioisotopes; Injections, Intravenous; Lung; Male; Monocrotaline; Platelet Count; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Splenectomy

1989
The effect of dietary restriction and altered sodium intake on the cardiopulmonary toxicity of monocrotaline pyrrole.
    Toxicology and applied pharmacology, 1985, Mar-30, Volume: 78, Issue:1

    Topics: Animals; Biotransformation; Body Weight; Cardiomegaly; Diet; Diet, Sodium-Restricted; L-Lactate Dehydrogenase; Lung Diseases; Male; Monocrotaline; Organ Size; Proteins; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Sodium

1985
The effect of immunosuppressants and adoptive transfer in monocrotaline pyrrole pneumotoxicity.
    Toxicology and applied pharmacology, 1987, Volume: 91, Issue:1

    Topics: Animals; Antilymphocyte Serum; Body Weight; Bronchoalveolar Lavage Fluid; Cyclosporins; Disease Models, Animal; Hypertension, Pulmonary; Hypertrophy; Immunization, Passive; Immunosuppressive Agents; L-Lactate Dehydrogenase; Lung; Lymphocytes; Male; Monocrotaline; Organ Size; Pyrrolizidine Alkaloids; Rats; Rats, Inbred F344; Rats, Inbred Strains

1987